Trial of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract, Lung, or Pancreas Who Have Not Received Prior Treatment With mTOR Inhibitors

Clinical trial NCT05997056 · RECRUITING

Trial details

NCT number: NCT05997056
Sponsor: Aadi Bioscience, Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Neuroendocrine Tumors NET Pancreatic Neuroendocrine Tumor Gastrointestinal Neuroendocrine Tumor Pulmonary Neuroendocrine Tumor

Start date: 2023-11-07
Primary completion: 2025-05-09
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.